Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Unichem Laboratories has informed about submission of the press release pertaining to receipt of ANDA approval from USFDA for Unichem's Chlorthalidone Tablets USP, 25 mg and 50 mg.
The above information is a part of company’s filings submitted to BSE.